Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...

The study analyzed electronic health records from 708,406 patients diagnosed with breast cancer between January 2011 and ...

Ozempic has officially arrived in India at a comparatively affordable price, sparking buzz among diabetes and weight loss patients alike. Experts break down how it works, who it’s meant for, and the ...

Type 2 diabetes is a recognized risk factor for vertebral fractures, which can lead to long-term disability and increased mortality. Although GLP-1 receptor agonists have demonstrated benefits in ...

Forget needles and prescriptions, one of the hottest trends in health right now is using nutrition and lifestyle to hack your ...

The launch comes after the approval from Medicines Evaluation Board (MEB), Netherlands, earlier this year, and will mark the ...

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500) and the Nasdaq (COMP:IND) ending the week in the ...

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...